Related Experiment Video

Updated: Jun 19, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

[Long-term use of oral antiplatelet therapy: from studies to practice]

Gérard Helft1

  • 1Service de cardiologie, Hôpital Pitié-Salpêtrière, Paris Cedex 13, F-75651, France. gerard.helft@psl.aphp.fr

Presse Medicale (Paris, France : 1983)
|November 3, 2009
PubMed

Insights

Antiplatelet therapies like aspirin and clopidogrel are vital for cardiovascular disease prevention. However, their use, especially in combination or for primary prevention, carries significant bleeding risks that must be carefully weighed.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Antiplatelet agents are crucial in managing cardiovascular diseases.
  • Aspirin and clopidogrel are widely used antiplatelet medications.
  • The benefit/risk profile of antiplatelet therapy varies between secondary and primary prevention.

Purpose of the Study:

  • To review the current role and risks of antiplatelet treatments in cardiovascular medicine.
  • To evaluate the efficacy and safety of combined antiplatelet therapy.
  • To anticipate the emergence of new antiplatelet agents.

Main Methods:

  • Literature review of antiplatelet treatments.
  • Analysis of clinical evidence for aspirin and clopidogrel.
  • Discussion of bleeding risks associated with antiplatelet therapy.

Main Results:

  • Antiplatelet therapy is essential for secondary cardiovascular prevention.
  • The benefit of antiplatelet therapy is less clear for primary prevention.
  • Combining antiplatelet agents increases efficacy for specific indications but significantly elevates bleeding risk.

Conclusions:

  • The judicious use of antiplatelet agents is critical, balancing efficacy against bleeding complications.
  • Dual antiplatelet therapy requires careful patient selection and indication.
  • Future antiplatelet drugs may offer enhanced efficacy but pose greater bleeding risks.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...